Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

2.

Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.

Drapier S, Raoul S, Drapier D, Leray E, Lallement F, Rivier I, Sauleau P, Lajat Y, Edan G, Vérin M.

J Neurol. 2005 May;252(5):583-8. Epub 2005 Mar 23.

PMID:
15778909
3.

SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.

Nunta-Aree S, Sitthinamsuwan B, Boonyapisit K, Pisarnpong A.

J Med Assoc Thai. 2010 May;93(5):529-40.

PMID:
20524438
4.

Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

Spottke EA, Volkmann J, Lorenz D, Krack P, Smala AM, Sturm V, Gerstner A, Berger K, Hellwig D, Deuschl G, Freund HJ, Oertel WH, Dodel RC.

J Neurol. 2002 Jun;249(6):759-66.

PMID:
12111311
5.

Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.

Paek SH, Han JH, Lee JY, Kim C, Jeon BS, Kim DG.

Neurosurgery. 2008 Nov;63(5):925-36; discussion 936-7. doi: 10.1227/01.NEU.0000334045.43940.FB.

PMID:
19005383
6.

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes.

Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G.

Mov Disord. 2006 Jun;21 Suppl 14:S290-304. Review.

PMID:
16892449
7.

Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.

Plaha P, Ben-Shlomo Y, Patel NK, Gill SS.

Brain. 2006 Jul;129(Pt 7):1732-47. Epub 2006 May 23.

PMID:
16720681
8.

Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.

Yoshida F, Miyagi Y, Kishimoto J, Morioka T, Murakami N, Hashiguchi K, Samura K, Sakae N, Yamasaki R, Kawaguchi M, Sasaki T.

Stereotact Funct Neurosurg. 2009;87(1):45-9. doi: 10.1159/000195719. Epub 2009 Jan 28.

PMID:
19174620
9.

Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.

Thobois S, Mertens P, Guenot M, Hermier M, Mollion H, Bouvard M, Chazot G, Broussolle E, Sindou M.

J Neurol. 2002 May;249(5):529-34.

PMID:
12021940
10.

Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.

Volkmann J, Albanese A, Kulisevsky J, Tornqvist AL, Houeto JL, Pidoux B, Bonnet AM, Mendes A, Benabid AL, Fraix V, Van Blercom N, Xie J, Obeso J, Rodriguez-Oroz MC, Guridi J, Schnitzler A, Timmermann L, Gironell AA, Molet J, Pascual-Sedano B, Rehncrona S, Moro E, Lang AC, Lozano AM, Bentivoglio AR, Scerrati M, Contarino MF, Romito L, Janssens M, Agid Y.

Mov Disord. 2009 Jun 15;24(8):1154-61. doi: 10.1002/mds.22496.

PMID:
19412954
11.

MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.

Patel NK, Plaha P, O'Sullivan K, McCarter R, Heywood P, Gill SS.

J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1631-7.

12.

Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients.

Erola T, Karinen P, Heikkinen E, Tuominen J, Haapaniemi T, Koivukangas J, Myllylä V.

Parkinsonism Relat Disord. 2005 Mar;11(2):89-94.

PMID:
15734666
13.

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N.

Brain. 2005 Oct;128(Pt 10):2240-9. Epub 2005 Jun 23.

PMID:
15975946
14.

Changes in health related quality of life in patients with Parkinson's disease with and without posteroventral pallidotomy.

D'Antonio LL, Zimmerman GJ, Iacono RP.

Acta Neurochir (Wien). 2000;142(7):759-67; discussion 767-8.

PMID:
10955670
15.

Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease.

Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J.

J Neurol Neurosurg Psychiatry. 2010 Mar;81(3):315-9. doi: 10.1136/jnnp.2009.184127. Epub 2009 Sep 1.

PMID:
19726415
16.

[Clinical utility of deep brain stimulation in an advanced Parkinson's disease].

Escamilla-Sevilla F, Mínguez-Castellanos A, Katati MJ, Martín-Linares JM, Meersmans M, Ortega-Moreno A, Arjona V.

Neurologia. 2004 Dec;19(10):719-27. Spanish.

PMID:
15568169
17.

Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.

Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP.

Arch Neurol. 2005 Apr;62(4):554-60.

PMID:
15824252
18.

Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.

Moro E, Esselink RJ, Benabid AL, Pollak P.

Brain. 2002 Nov;125(Pt 11):2408-17.

PMID:
12390968
19.

Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.

Wider C, Russmann H, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, Vingerhoets FJ.

Arch Neurol. 2006 Jul;63(7):951-5.

PMID:
16831963
20.

Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.

Kim HJ, Paek SH, Kim JY, Lee JY, Lim YH, Kim DG, Jeon BS.

Mov Disord. 2009 Feb 15;24(3):329-35. doi: 10.1002/mds.22211.

PMID:
19006187

Supplemental Content

Support Center